NCT06562192 Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers Status RECRUITING Phase PHASE1
NCT06549725 Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening Status RECRUITING Phase NA
NCT06528093 A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy Status TERMINATED Phase PHASE1
NCT06503146 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection Status RECRUITING Phase PHASE2
NCT06492915 Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06478862 Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy Status TERMINATED Phase PHASE2
NCT06445062 Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06428409 A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) Status RECRUITING Phase PHASE1/PHASE2
NCT06345599 PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study) Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06344299 Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase N/A
NCT06320717 AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma Status RECRUITING Phase N/A
NCT06305247 A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06302881 Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06287749 French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) Status RECRUITING Phase N/A
NCT06287463 Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway Status TERMINATED Phase PHASE1
NCT06276803 The LINFU® U.S. Registry for the in the General Population Without Risk Factors Status NOT_YET_RECRUITING Phase N/A
NCT06275737 POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric Status ACTIVE_NOT_RECRUITING Phase NA